Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
about
Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and TreatmentEpidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniaeThe Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniaeInfection with and Carriage of Mycoplasma pneumoniae in ChildrenPotential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and DiseaseComparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence FactorsAssociation of Mycoplasma pneumoniae infection with increased risk of asthma in childrenThe spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel.Mycoplasma Contamination of Cell Cultures: Vesicular Traffic in Bacteria and Control over Infectious AgentsCurrent and emerging Legionella diagnostics for laboratory and outbreak investigations.Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs.Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility.Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, ChinaSystematic Structural Analyses of Attachment Organelle in Mycoplasma pneumoniae.Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States.Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae, Chlamydia pneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens.Antimicrobial susceptibility and molecular characterization of macrolide resistance of Mycoplasma bovis isolates from multiple provinces in China.No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013.Effects of Traditional Chinese Medicine Qinbai Qingfei Concentrated Pellet on Cellular Infectivity of Mycoplasma pneumoniae.Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in ChildrenDrug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics.Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis.Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts.Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic.Nasopharyngeal disease in cats: 2. Specific conditions and their management.Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection.Structural Study of MPN387, an Essential Protein for Gliding Motility of a Human-Pathogenic Bacterium, Mycoplasma pneumoniae.Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.Mycoplasma pneumoniae thymidine phosphorylase.Solithromycin for the treatment of community-acquired bacterial pneumonia.Mycoplasma pneumoniae from the Respiratory Tract and Beyond.Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia.Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China.Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015.In Vitro Fractional Inhibitory Concentration (FIC) Study of Cefixime and Azithromycin Fixed Dose Combination (FDC) Against Respiratory Clinical Isolates.Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child.
P2860
Q26742180-097A9A7C-C273-4DC6-950B-B4B29EEEB71AQ26744683-441E4CC0-99D2-49FA-BA32-E0332C38B18BQ26751077-1ED00977-3B7F-45C2-9212-83E15BA89EFFQ26752332-9E0EFB14-2363-4472-9776-F913670BD52AQ26768548-67928DB3-D7AB-4BB2-8BCA-2CBB6B091D9AQ28547749-3B24B609-C6DF-4755-A602-6C30A8752E4EQ33723944-CFC52AD4-A97C-42A3-92E9-3A45CDAA251AQ34305578-4C01640B-A9D5-4E77-8253-0AB2379E51C5Q34394274-E0229BCA-1A7B-4159-BC93-E01A3094D0FFQ34826656-11C3F9F6-4017-4B80-B8D6-83EB3B618FE4Q34899246-79AE8C1E-9E17-48B3-9657-B9801F87D886Q35075260-C4B543CD-CD36-488A-A4FB-A6084F5D4D96Q35105923-686CFBBC-028E-4398-94CA-706936F21EA0Q35860090-5740B18E-88EA-4474-8397-B2DADD9371C4Q35952824-7DC9FDDE-7193-4EF6-8D20-6EC897AD0B35Q36269709-1E22774D-0DA0-481B-B774-81194246C2F5Q36669885-32368D8E-26BC-41DF-AD97-9F8477E7B62DQ36965933-083D75AE-8C70-4C10-A6F5-63B435BE7B12Q36978977-B1713218-6E06-44E0-B7BD-1CB20FA464D7Q37435982-1BC6F1E3-97C6-4073-872F-2DE96975141AQ37586821-38BD322A-E330-4318-9706-A0864D0EBA1FQ37713512-896F50F8-E9F5-4EF0-BBB4-94668C88190EQ37713726-099FF704-C49B-4F88-9577-72B1B6C3FEFCQ37844334-036D5BF6-71C9-4F8F-A6EE-868F51B7E135Q37847210-946620B5-DCA1-42CF-8E08-81516EEA206BQ38003357-E36FFF32-0A6C-4FCC-A4D6-4D0B575EBCD0Q38061407-7CB19BC5-671C-46C0-87A9-A329E6E6AC18Q38291944-1754418A-2E1C-4A4D-BFD3-583DF7B94D23Q39118434-DD3E921F-FCEA-41F9-BE83-AE7EF3F3DC09Q39157514-7274E99E-E960-46C2-AE50-4EBD8394DA76Q39174067-EDC4CB14-CB4C-48E8-9C63-0DF2F5D9F303Q39278428-F4C51E99-3BBD-4620-BB1D-7C136484A451Q39327219-D6BF1D76-C28D-4FDA-9B02-F5C3D0FBF160Q39424555-313DC562-0184-4FA8-AEAE-CA305B289945Q39850842-29AA13BE-88CA-48BF-BC55-C5C6B61C74B6Q40378895-3596D8FF-325B-41B8-9E25-D909ECAF03C9Q40448204-1B4514F4-766E-42A1-B1D7-896DF9C10DD6Q40868497-75F000C8-8463-4DFD-BA59-910907C3765FQ41093903-6BC742A3-EE83-4530-8B5A-66674D5AD847Q42692693-5D2AC110-EC50-4920-BC56-857652775B51
P2860
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
@en
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
@nl
type
label
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
@en
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
@nl
prefLabel
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
@en
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
@nl
P2860
P356
P1433
P1476
Mycoplasma pneumoniae: susceptibility and resistance to antibiotics
@en
P2093
Olivia Peuchant
P2860
P304
P356
10.2217/FMB.11.18
P577
2011-04-01T00:00:00Z